Medical News

RSS

Intra-Cellular Therapies announces results of its ITI-007 antipsychotic drug Phase I study

Intra-Cellular Therapies, Inc. (ITI) announced at a recent conference on neuropsychiatric diseases the results from a recently completed Phase I clinical study demonstrating ITI-007, the Company's lead antipsychotic drug, interacts with important targets in the living human brain. These key targets are critical to drug action in many neuropsychiatric and related disorders.

21 Dec 2009

Sanofi-aventis to acquire Chattem for $1.9 billion

Sanofi-aventis and Chattem, Inc. announced today that they have entered into a definitive agreement under which sanofi-aventis is to acquire 100 percent of the outstanding shares of Chattem in a cash tender offer for $93.50 per share, or approximately $1.9 billion.

21 Dec 2009

AcuMedSpa Holdings plans multiple acquisitions

AcuMedSpa Holdings, Inc. has been evaluating many acquisition prospects and currently is focused on multiple acquisition targets.

21 Dec 2009

First Edition: December 21, 2009

From today's headlines, the biggest overnight news is the Senate's vote to move its sweeping health reform bill one step closer to the finish line.

21 Dec 2009

Swedish agency approves Medivir's Xerclear for treatment of cold sores

The Swedish Medical Products Agency has now approved Xerclear™ for treatment of cold sores. It is the first and only topical treatment that has been demonstrated to prevent the incidence of cold sores and shorten healing-times. Xerclear™ will be available from pharmacies in the first half-year 2010.

21 Dec 2009

Book on physiology of eating and weight regulation

The development of effective preventive and therapeutic measures to control eating and body weight involves basic physiology as well as cognitive and social psychology.

21 Dec 2009

Positive interim results from Medicago's H5N1 vaccine Phase I human clinical trial

Medicago Inc. a biotechnology company focused on developing highly effective and affordable vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), today reported positive interim results from a Phase I human clinical trial with its H5N1 Avian Influenza vaccine candidate ("H5N1 vaccine"). The vaccine was found to be safe, well tolerated and also induced a solid immune response.

21 Dec 2009

Seattle Genetics and GSK sign ADC collaboration agreement

Seattle Genetics, Inc., announced today that it has entered into a collaboration agreement with GlaxoSmithKline (GSK) under which GSK will pay an upfront fee of $12 million for rights to utilize Seattle Genetics’ antibody-drug conjugate (ADC) technology with multiple antigens to be named by GSK.

21 Dec 2009

Fourth-quarter and full-year fiscal 2009 results announced by Prospect Medical Holdings

Prospect Medical Holdings, Inc., which owns and operates five community-based hospitals and manages the medical care of approximately 177,000 HMO enrollees in southern California, today announced financial results for its fiscal 2009 fourth quarter and year ended September 30, 2009.

21 Dec 2009

Elysium Internet launches new Chiropractor directory

Elysium Internet, Inc., an emerging leader in local performance based advertising and digital media, today announced that it has launched a new local Chiropractor directory under its recently acquired brand www.Chiropractor.net.

21 Dec 2009

Soligenix commences SGX201 Phase 1/2 clinical trial for acute radiation enteritis prevention

Soligenix, Inc., formerly known as DOR BioPharma, Inc., a late-stage biotechnology company, announced today that it has initiated a Phase 1/2 clinical trial evaluating SGX201, a time-release formulation of oral beclomethasone 17,21-dipropionate (oral BDP), for the prevention of acute radiation enteritis.

21 Dec 2009

MEDNAX acquires neonatal physician group in Louisiana

MEDNAX, Inc., today announced the acquisition of a neonatal physician group based in Alexandria, Louisiana.

21 Dec 2009

Repros Therapeutics receives NASDAQ notification

On December 15, 2009, Repros Therapeutics Inc. received notification from NASDAQ that it has not regained compliance with NASDAQ Listing Rules 5450(b)(2)(C) and 5450(b)(1). The first rule applies to the market value of publicly held shares and the latter is the requirement of a minimum of a $1 share price.

21 Dec 2009

Leicester doctor becomes President of International Federation for Emergency Medicine

A Leicester doctor who was a pioneer in developing emergency medical care in Leicestershire and throughout the world has become the first elected President of the International Federation for Emergency Medicine.

21 Dec 2009

Evidence Based Associates presents award to the FFT/Redirection program

On November 12, 2009, Evidence Based Associates presented an award to the FFT/Redirection program at the Institute for Child & Family Health. The Redirection Program is a community-based, family-centered alternative to residential juvenile justice commitment programs.

21 Dec 2009

Preliminary results from Phase III study of afamelanotide in EPP announced

Clinuvel Pharmaceuticals Limited today announced that it has obtained promising 4-months results in testing afamelanotide in a multicentre randomised double-blind placebo controlled Phase III study in EPP (CUV017).

21 Dec 2009

Probiotic hangover cure

The holiday season can be a real headache for employers as absenteeism increases as the party season approaches. Everyone looks forward to the parties, social gatherings and family meals as opportunities to abandon self-discipline and enjoy all that the festive season has to offer. Even the most disciplined can end up feeling “under the weather” the morning after and this often leads to a sick day.

21 Dec 2009

Medical News

Intra-Cellular Therapies announces results of its ITI-007 antipsychotic drug Phase I study

Sanofi-aventis to acquire Chattem for $1.9 billion

AcuMedSpa Holdings plans multiple acquisitions

First Edition: December 21, 2009

Swedish agency approves Medivir's Xerclear for treatment of cold sores

Book on physiology of eating and weight regulation

Positive interim results from Medicago's H5N1 vaccine Phase I human clinical trial

Seattle Genetics and GSK sign ADC collaboration agreement

Fourth-quarter and full-year fiscal 2009 results announced by Prospect Medical Holdings

Elysium Internet launches new Chiropractor directory

Soligenix commences SGX201 Phase 1/2 clinical trial for acute radiation enteritis prevention

MEDNAX acquires neonatal physician group in Louisiana

Repros Therapeutics receives NASDAQ notification

Leicester doctor becomes President of International Federation for Emergency Medicine

Evidence Based Associates presents award to the FFT/Redirection program

Preliminary results from Phase III study of afamelanotide in EPP announced

Probiotic hangover cure

The Ensign Group declares a quarterly dividend of $0.05 per share

Embryo biopsy does not adversely affect health of newborn singleton PGD/PGS children

Medical experts recognize surgery as legitimate and effective treatment for type 2 diabetes

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Latest News